Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

This publication has 11 references indexed in Scilit:

• Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination
  Vaccine, 1996
• Hepatitis B vaccine boosting: the debate continues
  The Lancet, 1995
• Adjuvants for human vaccines—current status, problems and future prospects
  Vaccine, 1995
• A prospective study of in vitro anti‐HBs producing B cells (spot‐ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls
  Journal of Medical Virology, 1991
• Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients
  The American Journal of Medicine, 1989
• Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers
  JAMA, 1989
• Global Control of Hepatitis B Through Vaccination: Role of Hepatitis B Vaccine in the Expanded Programme on Immunization
  Clinical Infectious Diseases, 1989
• Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness
  Vaccine, 1988
• Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men
  New England Journal of Medicine, 1986
• A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report
  Hepatology, 1981